NCT03778840View on ClinicalTrials.gov

Study of Infections in Patients With Autoimmune Diseases Treated With Rituximab

CompletedOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

May 29, 2019

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
Autoimmune Diseases
Trial Locations (1)

Unknown

Hôpital Claude Huriez, CHU, Lille

All Listed Sponsors
collaborator

Grifols Biologicals, LLC

INDUSTRY

lead

University Hospital, Lille

OTHER

NCT03778840 - Study of Infections in Patients With Autoimmune Diseases Treated With Rituximab | Biotech Hunter | Biotech Hunter